Hence, intracellular glutathione depletion has been proposed as a mechanism for nSMase2 activation [21,22,23,24,25], especially since elevated glutathione levels in tumor cells were associated with tumor progression and increased resistance to chemotherapeutic drugs [26,27,28]. The gene discussed is SMPD3; the disease is neoplasm.